Medtronic will bring its next-generation surgical robotics offering to The Surgeon Show, where attendees can see live demonstrations of the Hugo™ Robotic-Assisted Surgery (RAS) system alongside the company’s Touch Surgery™ digital training and education platform.
The appearance comes as Medtronic continues to expand the footprint of Hugo™ RAS internationally. The modular and portable system, developed for soft-tissue surgery—is now FDA cleared in the United States for urologic procedures and CE-marked for soft tissue abdominal procedures including urological, gynaecological, colorectal and general surgeries in Europe, positioning it as an increasingly prominent option in the fast-moving global robotic surgery landscape.
At the centre of Hugo™ RAS is a modular design built around independent arm carts, enabling teams to configure the system from one to four robotic arms depending on the needs of each case. The platform also features an open surgeon console, intended to support greater communication and coordination between the surgeon and the wider operating theatre team.
Medtronic says the flexible set-up supports multi-quadrant access, allowing teams to tackle more complex procedures while helping maintain smooth workflow - particularly in environments where space, set-up time and adaptability are key operational priorities.
Vanessa Lowe, Senior Business Unit Director, Medtronic Surgical, UK and Ireland: “At The Surgeon Show, we’re looking forward to demonstrating how Hugo™ RAS has been designed to fit into real clinical environments, bringing modularity, flexibility and choice to robotic-assisted surgery. By integrating Touch Surgery™ training and post-operative analytics, we’re also helping teams build skills and insight that support continuous improvement, both in and beyond the operating theatre.”
Alongside the robotics hardware, Medtronic will also highlight integration with Touch Surgery™ Enterprise, a cloud-based platform that combines interactive training content, surgical video recording, live streaming, and post-operative analytics designed to support surgeon education and performance improvement.
The company will also showcase the LigaSure™ Maryland RAS vessel-sealing instrument, CE-marked in 2025 for use with Hugo™ RAS, bringing its established vessel‑sealing capability into a robotic‑assisted setting.
Visitors to Medtronic’s booth at The Surgeon Show will be able to see the Hugo™ RAS system in action, alongside demonstrations of Touch Surgery™ live streaming, providing a hands-on view of how robotic platforms, training tools and analytics are increasingly converging to support modern surgical practice.
The Surgeon Show 2026 will bring together senior surgical leaders and industry innovators for a programme shaped around conversation and debate, exploring the issues influencing the future of surgery - from the operating theatre of tomorrow to the growing role of AI, robotics and advanced technologies in clinical practice.
The event is invitation-only, with registration of interest available via surgeonshow.com.
Disclaimers
The Medtronic Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, or market availability. Indications for use may vary. Risks may include arrythmia, bleeding, burns, infection, tissue damage or other complications.
The Medtronic Touch Surgery™ ecosystem is not intended to direct surgery, or aid in diagnosis or treatment of a disease or condition. Please note: Performance Insights are available for select procedures, instruments, and anatomy.
